These IC immune receptors have been previously demonstrated to control antiviral and antitumor CD8+ T-cell effector function in experimental models of lymphocytic choriomeningitis virus (LCMV) and in humans with advanced melanoma (27, 28). This evidence concerns the gene CD8A and melanoma.